Location History:
- Kawagoe, JP (1999 - 2012)
- Saitama, JP (2000 - 2016)
Company Filing History:
4 out of 11 
2 out of 2 
2 out of 2 Years Active: 1999-2016
Title: Kazuyuki Ogawa: Innovator in Therapeutic Agents for Infections
Introduction
Kazuyuki Ogawa is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of infections. With a total of 6 patents to his name, Ogawa's work focuses on developing solutions that minimize side effects and combat bacterial resistance.
Latest Patents
Ogawa's latest patents include a therapeutic agent for infections that utilizes granulysin as an active ingredient. The invention aims to provide a treatment that has minimal side effects and no cytotoxicity, while also being resistant to bacterial adaptation. The therapeutic agent comprises 15K granulysin, either alone or in combination with various interleukins such as IL-6, IL-23, or IL-27. This innovative approach enhances the killing effects on bacteria and offers a promising solution for infection treatment.
Career Highlights
Throughout his career, Kazuyuki Ogawa has worked with reputable organizations, including BML, Inc. and the National Hospital Organization Kinki-chuo Chest Medical Center. His experience in these institutions has contributed to his expertise in developing effective therapeutic agents.
Collaborations
Ogawa has collaborated with notable colleagues, including Kinya Nagata and Syoichi Takano. These partnerships have likely enriched his research and development efforts in the field of infection treatment.
Conclusion
Kazuyuki Ogawa's innovative work in therapeutic agents for infections showcases his commitment to advancing medical science. His contributions are vital in addressing the challenges posed by bacterial resistance and improving patient outcomes.